182 related articles for article (PubMed ID: 8420145)
1. Mitochondrial complex I deficiency in Parkinson's disease.
Schapira AH
Adv Neurol; 1993; 60():288-91. PubMed ID: 8420145
[No Abstract] [Full Text] [Related]
2. Mitochondrial energy crisis in Parkinson's disease.
Mizuno Y; Ikebe S; Hattori N; Kondo T; Tanaka M; Ozawa T
Adv Neurol; 1993; 60():282-7. PubMed ID: 8420144
[No Abstract] [Full Text] [Related]
3. Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal.
Schapira AH
Mov Disord; 1994 Mar; 9(2):125-38. PubMed ID: 8196673
[TBL] [Abstract][Full Text] [Related]
4. L-dihydroxyphenylalanine and complex I deficiency in Parkinson's disease brain.
Cooper JM; Daniel SE; Marsden CD; Schapira AH
Mov Disord; 1995 May; 10(3):295-7. PubMed ID: 7651446
[TBL] [Abstract][Full Text] [Related]
5. Complex I, iron, and ferritin in Parkinson's disease substantia nigra.
Mann VM; Cooper JM; Daniel SE; Srai K; Jenner P; Marsden CD; Schapira AH
Ann Neurol; 1994 Dec; 36(6):876-81. PubMed ID: 7998774
[TBL] [Abstract][Full Text] [Related]
6. Iron-dependent enzymes in Parkinson's disease.
Reichmann H; Janetzky B; Riederer P
J Neural Transm Suppl; 1995; 46():157-64. PubMed ID: 8821051
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease and the electron transport chain in postmortem brain.
Reichmann H; Lestienne P; Jellinger K; Riederer P
Adv Neurol; 1993; 60():297-9. PubMed ID: 8380522
[No Abstract] [Full Text] [Related]
8. Are dopaminergic neurons selectively vulnerable to Parkinson's disease?
Agid Y; Ruberg M; Javoy-Agid F; Hirsch E; Raisman-Vozari R; Vyas S; Faucheux B; Michel P; Kastner A; Blanchard V
Adv Neurol; 1993; 60():148-64. PubMed ID: 8420132
[No Abstract] [Full Text] [Related]
9. Mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group.
Schapira AH; Mann VM; Cooper JM; Krige D; Jenner PJ; Marsden CD
Ann Neurol; 1992; 32 Suppl():S116-24. PubMed ID: 1510369
[TBL] [Abstract][Full Text] [Related]
10. Iron and ferritin in substantia nigra in Parkinson's disease.
Jellinger KA; Kienzl E; Rumpelmaier G; Paulus W; Riederer P; Stachelberger H; Youdim MB; Ben-Shachar D
Adv Neurol; 1993; 60():267-72. PubMed ID: 8420142
[No Abstract] [Full Text] [Related]
11. [Mechanism of cell death in neurodegenerative disorders: apropos of Parkinson disease].
Agid Y
C R Seances Soc Biol Fil; 1993; 187(1):37-46. PubMed ID: 8242421
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.
Gu M; Owen AD; Toffa SE; Cooper JM; Dexter DT; Jenner P; Marsden CD; Schapira AH
J Neurol Sci; 1998 Jun; 158(1):24-9. PubMed ID: 9667773
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial DNA analysis in Parkinson's disease.
Schapira AH; Holt IJ; Sweeney M; Harding AE; Jenner P; Marsden CD
Mov Disord; 1990; 5(4):294-7. PubMed ID: 1979656
[TBL] [Abstract][Full Text] [Related]
14. Oxidative mechanisms in nigral cell death in Parkinson's disease.
Jenner P
Mov Disord; 1998; 13 Suppl 1():24-34. PubMed ID: 9613715
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial DNA in Parkinson's disease.
Schapira AH
Adv Neurol; 1999; 80():233-7. PubMed ID: 10410727
[No Abstract] [Full Text] [Related]
16. [Parkinson disease--a mitochondrial myopathy?].
Reichmann H; Janetzky B; Klinge M; Riederer P
Nervenarzt; 1993 Apr; 64(4):215-20. PubMed ID: 8506008
[No Abstract] [Full Text] [Related]
17. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease.
Hattori N; Ikebe S; Tanaka M; Ozawa T; Mizuno Y
Adv Neurol; 1993; 60():292-6. PubMed ID: 8380521
[No Abstract] [Full Text] [Related]
18. Pathogenesis and animal studies of Parkinson's disease.
Oertel WH; Kupsch A
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):323-32. PubMed ID: 8507901
[TBL] [Abstract][Full Text] [Related]
19. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
20. Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease.
Jenner P
Acta Neurol Scand Suppl; 1993; 146():6-13. PubMed ID: 8333254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
